Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway

Ganoderma lucidum has been widely used as a remedy to promote health and longevity in China. The polysaccharide component with a branched (1→3)‐β‐D‐glucan moiety from G. lucidum (PS‐G) has shown evidence of enhancement of immune responses and of eliciting anti‐tumor effects. In this study, we invest...

Full description

Saved in:
Bibliographic Details
Published inJournal of leukocyte biology Vol. 72; no. 1; pp. 207 - 216
Main Authors Hsu, Ming‐Jen, Lee, Shiuh‐Sheng, Lin, Wan‐Wan
Format Journal Article
LanguageEnglish
Published United States Society for Leukocyte Biology 01.07.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ganoderma lucidum has been widely used as a remedy to promote health and longevity in China. The polysaccharide component with a branched (1→3)‐β‐D‐glucan moiety from G. lucidum (PS‐G) has shown evidence of enhancement of immune responses and of eliciting anti‐tumor effects. In this study, we investigated the effect of PS‐G on neutrophil viability, which is manifested by spontaneous apoptosis. Annexin V staining and MTT assays reveal that PS‐G is able to inhibit spontaneous and Fas‐induced neutrophil apoptosis, and this effect of PS‐G is enhanced by the presence of zVAD (a caspase inhibitor) and GM‐CSF. The antiapoptotic effect of PS‐G is diminished by the presence of wortmannin and LY294002 (two PI‐3K inhibitors), but is not altered by PD98059 (a MEK inhibitor). Western blotting indicates the stimulating effect of PS‐G on Akt phosphorylation and its inhibition of procaspase 3 degradation, which occurs in neutrophils undergoing spontaneous apoptosis or triggered death by Fas. Taken together, PS‐G elicitation of antiapoptotic effects on neutrophils primarily relies on activation of Akt‐regulated signaling pathways.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0741-5400
1938-3673
DOI:10.1189/jlb.72.1.207